Literature DB >> 23043603

Hepatitis C virus and other risk factors in hepatocellular carcinoma.

E Schiefelbein1, A-R Zekri, D W Newton, G A Soliman, M Banerjee, Ch-W Hung, I A Seifeldin, A-Ch Lo, A S Soliman.   

Abstract

UNLABELLED: Hepatocellular carcinoma (HCC) increased in Egypt in the past years, becoming the most common cancer among men. Hepatitis B virus (HBV) and hepatitis C virus (HCV) are the known primary risk factors for HCC. This study describes the viral profile of HCC in a predominantly rural area in Egypt. We included 148 HCC cases and 148 controls from the Tanta Cancer Center and the Gharbiah Cancer Society in the Nile delta region. Serological (ELISA) and molecular (PCR) analysis for HBV and HCV infection were performed on plasma samples from each subject. Epidemiologic, environmental, and medical histories were collected by interviewing of subjects. Around 90.5% of cases and controls were from rural areas. HCV infection was high in both cases and controls (89.2% and 49.3%, for cases and controls respectively by serology). HCV was the most important HCC risk factor [OR 9.7 (95% CI: 3.3-28.0, P <0.01)], and HBV infection showed marginal tendency of increased risk [OR 5.4 (95% CI: 0.9-31.8, P <0.06)]. Ever worked in farming [OR 2.8 (95% CI: 1.1-7.2, P <0.03)] and history of cirrhosis [OR 3.6 (95% CI: 1.6-8.1, P <0.01)] or blood transfusion [OR 4.2 (95% CI: 0.99-17.8, P <0.05)] were also associated with increased HCC risk. This study in a predominantly rural area in Egypt supports previous reports from other parts of Egypt that HCV infection is the primary HCC risk factor in Egypt. Further understanding of the relationship between infection and other risk factors in the development of HCC could lead to targeted interventions for at-risk individuals. KEYWORDS: hepatocellular carcinoma; hepatitis; rural; risk factors; Egypt.

Entities:  

Mesh:

Year:  2012        PMID: 23043603      PMCID: PMC4274948          DOI: 10.4149/av_2012_03_235

Source DB:  PubMed          Journal:  Acta Virol        ISSN: 0001-723X            Impact factor:   1.162


  26 in total

1.  Hepatitis c and cirrhotic liver disease in the Nile delta of Egypt: a community-based study.

Authors:  M A Darwish; R Faris; N Darwish; A Shouman; M Gadallah; M S El-Sharkawy; R Edelman; K Grumbach; M R Rao; J D Clemens
Journal:  Am J Trop Med Hyg       Date:  2001 Mar-Apr       Impact factor: 2.345

2.  Epidemiologic risk factors of hepatocellular carcinoma in a rural region of Egypt.

Authors:  Amr S Soliman; Chu-Wei Hung; Alexander Tsodikov; Ibrahim A Seifeldin; Mohamed Ramadan; Dina Al-Gamal; Emily L Schiefelbein; Priyanka Thummalapally; Subhojit Dey; Kadry Ismail
Journal:  Hepatol Int       Date:  2010-08-19       Impact factor: 6.047

3.  Associations of pesticides, HCV, HBV, and hepatocellular carcinoma in Egypt.

Authors:  Sameera Ezzat; Mohamed Abdel-Hamid; Soheir Abdel-Latif Eissa; Nadia Mokhtar; Nargis Albert Labib; Laila El-Ghorory; Nabiel Nasmi Mikhail; Amany Abdel-Hamid; Tamer Hifnawy; G Thomas Strickland; Christopher A Loffredo
Journal:  Int J Hyg Environ Health       Date:  2005       Impact factor: 5.840

4.  Global cancer statistics, 2002.

Authors:  D Max Parkin; Freddie Bray; J Ferlay; Paola Pisani
Journal:  CA Cancer J Clin       Date:  2005 Mar-Apr       Impact factor: 508.702

Review 5.  Primary liver cancer: worldwide incidence and trends.

Authors:  F Xavier Bosch; Josepa Ribes; Mireia Díaz; Ramon Cléries
Journal:  Gastroenterology       Date:  2004-11       Impact factor: 22.682

6.  Hepatocellular carcinoma in Mansoura-Egypt: experience of 385 patients at a single center.

Authors:  M Abdel-Wahab; A A el-Enein; M Abou-Zeid; A el-Fiky; T Abdallah; M Fawzy; A Fouad; A Sultan; O Fathy; G el-Ebidy; N elghawalby; F Ezzat
Journal:  Hepatogastroenterology       Date:  2000 May-Jun

7.  Hepatocellular carcinoma in Egypt: a single center study over a decade.

Authors:  Abdel-Rahman el-Zayadi; Hanaa M Badran; Eman M F Barakat; Mohy el-Deen Attia; Sherine Shawky; Mostafa K Mohamed; Osaima Selim; Ahmed Saeid
Journal:  World J Gastroenterol       Date:  2005-09-07       Impact factor: 5.742

Review 8.  Epidemiology and prevention of hepatocellular carcinoma.

Authors:  Silvia Franceschi; Syed Ahsan Raza
Journal:  Cancer Lett       Date:  2008-12-12       Impact factor: 8.679

9.  Cancer statistics, 2009.

Authors:  Ahmedin Jemal; Rebecca Siegel; Elizabeth Ward; Yongping Hao; Jiaquan Xu; Michael J Thun
Journal:  CA Cancer J Clin       Date:  2009-05-27       Impact factor: 508.702

10.  Hepatitis C virus infection at Sharkia Governorate, Egypt: seroprevalence and associated risk factors.

Authors:  Mahmoud el-Sadawy; Hosnia Ragab; Hanan el-Toukhy; Abd el-Latif el-Mor; Amal M Mangoud; Mostafa H Eissa; Afefy F Afefy; Eman el-Shorbagy; Ibrahem A Ibrahem; Seham Mahrous; Amal Abdel-Monem; Essam I Sabee; Alaa Ismail; Tosson A Morsy; Samia Etewa; Essam Nor Edin; Yousry Mostafa; Yousry Abouel-Magd; Mostafa I Hassan; Khalid Lakouz; Khalid Abdel-Aziz; Gaber el-Hady; Mahmoud Saber
Journal:  J Egypt Soc Parasitol       Date:  2004-04
View more
  7 in total

Review 1.  Pesticide exposure and liver cancer: a review.

Authors:  Trang VoPham; Kimberly A Bertrand; Jaime E Hart; Francine Laden; Maria M Brooks; Jian-Min Yuan; Evelyn O Talbott; Darren Ruddell; Chung-Chou H Chang; Joel L Weissfeld
Journal:  Cancer Causes Control       Date:  2017-02-13       Impact factor: 2.506

2.  Yttrium-90 microsphere radioembolisation for unresectable hepatocellular carcinoma.

Authors:  Omar Abdel-Rahman; Zeinab Elsayed
Journal:  Cochrane Database Syst Rev       Date:  2020-01-24

Review 3.  Combination trans arterial chemoembolization (TACE) plus sorafenib for the management of unresectable hepatocellular carcinoma: a systematic review of the literature.

Authors:  O Abdel-Rahman; Z A Elsayed
Journal:  Dig Dis Sci       Date:  2013-09-18       Impact factor: 3.487

4.  Sorafenib versus capecitabine in the management of advanced hepatocellular carcinoma.

Authors:  Omar Abdel-Rahman; Manal Abdel-Wahab; Mohammed Shaker; Sherif Abdel-Wahab; Mohammed Elbassiony; Mahmoud Ellithy
Journal:  Med Oncol       Date:  2013-07-04       Impact factor: 3.738

5.  The effectiveness of stem cell therapies on health-related quality of life and life expectancy in comparison with conventional supportive medical treatment in patients suffering from end-stage liver disease.

Authors:  Adeeb M AlZoubi; Farah Khalifeh
Journal:  Stem Cell Res Ther       Date:  2013-02-25       Impact factor: 6.832

Review 6.  Relative Importance of Hepatitis B and C Viruses in Hepatocellular Carcinoma in EMRO Countries and the Middle East: A Systematic Review.

Authors:  Seyed Moayed Alavian; Hossein Haghbin
Journal:  Hepat Mon       Date:  2016-03-06       Impact factor: 0.660

7.  Hepatitis B, C and D virus infections and risk of hepatocellular carcinoma in Africa: A meta-analysis including sensitivity analyses for studies comparable for confounders.

Authors:  Donatien Serge Mbaga; Sebastien Kenmoe; Cyprien Kengne-Ndé; Jean Thierry Ebogo-Belobo; Gadji Mahamat; Joseph Rodrigue Foe-Essomba; Marie Amougou-Atsama; Serges Tchatchouang; Inès Nyebe; Alfloditte Flore Feudjio; Ginette Irma Kame-Ngasse; Jeannette Nina Magoudjou-Pekam; Lorraine K M Fokou; Dowbiss Meta-Djomsi; Martin Maïdadi-Foudi; Sabine Aimee Touangnou-Chamda; Audrey Gaelle Daha-Tchoffo; Abdel Aziz Selly-Ngaloumo; Rachel Audrey Nayang-Mundo; Jacqueline Félicité Yéngué; Jean Bosco Taya-Fokou; Raoul Kenfack-Momo; Efietngab Atembeh Noura; Cynthia Paola Demeni Emoh; Hervé Raoul Tazokong; Arnol Bowo-Ngandji; Carole Stéphanie Sake; Etienne Atenguena Okobalemba; Jacky Njiki Bikoi; Richard Njouom; Sara Honorine Riwom Essama
Journal:  PLoS One       Date:  2022-01-21       Impact factor: 3.752

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.